Pulmonx reported 5% lower Q2 2026 revenue despite record gross margins, citing China sales delays. The company expects full-year 2026 revenue of $90M to $92M.
Pulmonx reported 5% lower Q2 2026 revenue despite record gross margins, citing China sales delays. The company expects full-year 2026 revenue of $90M to $92M.